Dogwood Therapeutics【DWTX】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

2.5197

買値

2.33

売値

2.65

出来高

0.00 日の範囲 0.00

1.62 52 週間の範囲 5.29

前日終値

2.5197

始値

時刻

最終取引時間

平均取引量 (3 か月)

112,477

財務取引量

VWAP

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

- IMC-2 treatment, dosed as valacyclovir 750 mg + celecoxib 200 mg twice daily, demonstrated clinically meaningful reduction in Long-COVID related fatigue and sleep disturbance as compared to...

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

- Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) formed in October by combination of Virios Therapeutics, Inc. and Pharmagesic (Holdings) Inc., 100% parent company of Wex Pharmaceuticals, Inc. (the...

Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024

ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)

Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million to fund operations and advance Phase 2b Halneuron®...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.0803	-3.08846153846	2.6	2.7009	2.37	19153	2.45383339	CS
4	-1.8103	-41.8083140878	4.33	4.7067	1.62	79341	2.67896784	CS
12	-1.0303	-29.0225352113	3.55	5.29	1.62	112477	3.61113657	CS
26	-1.0303	-29.0225352113	3.55	5.29	1.62	112477	3.61113657	CS
52	-1.0303	-29.0225352113	3.55	5.29	1.62	112477	3.61113657	CS
156	-1.0303	-29.0225352113	3.55	5.29	1.62	112477	3.61113657	CS
260	-1.0303	-29.0225352113	3.55	5.29	1.62	112477	3.61113657	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
PRFXPainReform Ltd	US$ 6.50 (142.54%)	13.82M
BJDXBluejay Diagnostics Inc	US$ 7.79 (100.26%)	8.12M
PBMPsyence Biomedical Ltd	US$ 3.62 (43.65%)	12.35M
SVMHSRIVARU Holding Ltd	US$ 0.0316 (34.47%)	197.19M
TARAProtara Therapeutics Inc	US$ 4.72 (33.33%)	3.17M
BLUEbluebird bio Inc	US$ 0.4976 (-32.42%)	991.53k
CYCNCyclerion Therapeutics Inc	US$ 4.70 (-25.98%)	194.66k
STECSantech Holdings Limited	US$ 0.7309 (-24.65%)	3.81M
SRMSRM Entertainment Inc	US$ 0.8933 (-22.99%)	809.06k
NCNOnCino Inc	US$ 34.20 (-19.53%)	48.23k
SVMHSRIVARU Holding Ltd	US$ 0.0316 (34.47%)	197.19M
PRFXPainReform Ltd	US$ 6.49 (142.16%)	13.83M
PBMPsyence Biomedical Ltd	US$ 3.62 (43.65%)	12.35M
BJDXBluejay Diagnostics Inc	US$ 7.79 (100.26%)	8.12M
MIGIMawson Infrastructure Group Inc	US$ 0.8045 (18.29%)	7.84M